How should sirolimus be used in clinical practice?
Manchester Royal Infirmary, Manchester, UK.
R W G
RW
Johnson
D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects; D005919:Glomerular Filtration Rate; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D020123:Sirolimus